Company Quick10K Filing
Sunshine Biopharma
10-Q 2020-03-31 Filed 2020-05-18
10-K 2019-12-31 Filed 2020-05-01
10-Q 2019-09-30 Filed 2019-11-13
10-Q 2019-06-30 Filed 2019-08-15
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-12
S-1 2018-10-09 Public Filing
10-Q 2018-09-30 Filed 2018-11-16
10-Q 2018-06-30 Filed 2018-08-17
10-Q 2018-03-31 Filed 2018-05-22
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-15
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-16
10-Q 2016-03-31 Filed 2016-05-09
10-K 2015-12-31 Filed 2016-03-25
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-03-11
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-12
10-Q 2014-03-31 Filed 2014-05-09
10-K 2013-12-31 Filed 2014-03-19
10-Q 2013-09-30 Filed 2013-11-04
10-Q 2013-06-30 Filed 2013-08-06
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-15
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-08
10-K 2011-12-31 Filed 2012-03-19
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-12
10-K 2010-12-31 Filed 2011-03-30
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-04
10-Q 2010-03-31 Filed 2010-04-30
8-K 2020-06-17
8-K 2020-05-22
8-K 2020-04-13
8-K 2019-06-30
8-K 2019-03-12
8-K 2018-09-10
8-K 2018-01-01

Sunshine Biopharma Financials

SBFM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Bulova Technologies (BTGI)
Jiayin Group (JFIN)
Amplitude Healthcare (AMHCU)
X Rail Entertainment (XREE) 0 -0.1 -1,441,401% 0 3,429 0 0 -5,261 -5,732 345
Triton Emission Solutions (DSOX) 0 0.0 -10,306% 20 18,837 0 0 -2,068 -831 -1
PropTech Acquisition Corp (PTACU)
Cantabio Pharmaceuticals (CTBO) 0 0.9 -474% 326 2,215 0 0 -1,543 -331 -283
DigitalTown (DGTW) 0 12,618% 0.0 -16,557% 34 2,761 -2 -220 -5,706 -5,268 -34
Natcore Technology (NXT)
GIFA (FRFS) 0 63% -0.9 43% 80 362 98 62 34 34 -30
Highcom Global Security (HCGS) 0 41% -0.8 1% 9,334 1,222 4,918 2,033 57 172 -131
OncBioMune (OBMP) 0 0.0 -1,707% 413 14,090 0 0 -7,048 -5,617 -136
True Drinks Holdings (TRUU) 0 57% 1.7 -26% 9,780 7,642 12,437 7,052 -2,515 -2,482 -4,166
Bingo Nation (BLTO)
Life Clips (LCLP) 0 135% -0.7 -21,823% 16 9,270 -86 -116 -3,494 -3,182 2,355
Premier Biomedical (BIEI) 0 58% -0.3 -183% 186 2,304 13 8 -340 -238 75
Electromedical Technologies (ELCQ)
Sunshine Biopharma (SBFM) 0 30% 0.1 -864% 146 889 130 38 -1,264 -1,160 -82
Ozop Surgical (OZSC) 0 90% -0.7 -71% 6,256 10,414 85 76 -4,437 -2,958 1,985
Data Call Technologies (DCLT) 0 70% 0.7 -21% 101 73 463 323 -21 -19 -13

Balance Sheet ($'000)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1181011786138632551332561577131703817414314915712551123742257171291881081053646115953782
Accounts Receivable210377192108103951191
Inventory131818
PP&E4466652758601183002802692543936
Assets159143224106841092681352591617231724418014314917113767383174259964231642562571,0021,1701,1041,1471,247109146
Accounts Payable00538172180924509451354736354724361928283512191131391051911408465
Long-Term Debt007080000290
Liabilities005321291564221524391853824575313794364701,2701,1861,2142772742847816108311,5031,4461,0601,2021,459926889
Stockholders' Equity22010364802537023714648-8-113-338-276-388-231-265-333-597-355-471323-210-261-616-354-573-501-27645-56-212-816-743
Income Statement ($'000)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000000000000200000000009110713712037
Cost of Revenue921038515
Gross Profit16343522
R&D180012502002323011496323040090330000015
SG&A6416134497391033761889236971786854068662773111253701131747038211633610947211416225863131415668205
Tax00000000000000000000000000000
Net Income-49-16-116-372-39-26-377-189-1,477-1,251-178-686-501-818-281-334-294-518-203-648-305-392-1,586-1,124-196904-148-211-266-644-908-203-711-350
Cash Flow ($'000)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-44-61-118-118-35-25-160-173-340-99-86-40-91-182-78-188-113-305-106-344-82-138-63-31-108-78-148-209-168-124-104-234-46-88
Cash Investing0000000000000000-6240-20-10-2222-84-805800-13-1
Cash Financing001960125035250463000130150214157118313748931648011696620918121424911052155133